Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Chicago Charity Gala Event Raised $2,157,201 to Fund Invaluable Cancer Research
  • USA - English


News provided by

Gateway for Cancer Research

Nov 26, 2014, 03:00 ET

Share this article

Share toX

Share this article

Share toX


At Gateway we believe cures for cancer are within reach, and with the achievements of the Cures Gala fundraiser, we are significantly closer to realizing that vision.

Post this

SCHAUMBURG, Ill (PRWEB) November 26, 2014 -- Cures Gala themed Heroes Among Us was an epic event to bravely conquer cancer and renew hope for cancer patients today. Over 1000 heroines and heroes gloriously assembled at the Sheraton Chicago on Saturday, Nov. 15, 2014, in an effort to raise nearly $2.2 million for innovative cancer clinical trials. The contributions that evening will drive new promising cancer research and more treatment options for patients around the world. Mr. Jarrett W. Payton presided as Cures Gala Master of Ceremonies for the second year as he shared his personal story about losing his superhero, the late, great Walter Payton, to cancer 15 years ago.

“He was my biggest role model, he was my hero and he was my best friend,” said Payton, as he inspired guests to boldly make a difference in cancer research.

Mr. Bruce Lubin, The PrivateBank, was this year’s Cures Gala Honorary Chair and was honored that night with the first ever Gateway Impact Award – given in recognition of Lubin’s longstanding commitment to Gateway’s mission to help people living with cancer feel better, live longer and conquer cancer today!

“Gateway is continuously seeking to develop deep and meaningful relationships with leading innovators who are at the forefront of cancer research and persistently searching for novel and alternative ideas to treat cancer. Gateway is determined to give cancer researchers the funds they need to make cures a reality,” said Mr. Lubin, as he challenged the guests to recommit themselves to Gateway’s vision of “shaping a world in which a cancer diagnosis is no longer feared.”

Musical entertainment was provided by the Netherlands (NL) sensation, Guido Dieteren and Guido’s Orchestra which combines pop genre with classical music. As a tribute to Guido’s father who died after battling cancer, Guido composed “Song of Hope” which was performed for the first time at the Gala.

Honored special guests included Academy Award nominee Terrence Howard, who gave an incredible monologue about his mother and her battle with cancer. Mr. Howard also spoke passionately about events like Gateway’s Cures Gala that have a significant impact on phase 1 and phase 2 clinical trials as they traditionally receive very little research funding and are absolutely necessary for cancer treatments to move from the laboratory to the patient.

Other honored guests were Gateway’s “Researcher of the Year” Dr. Edward Lin of Seattle Cancer Care Alliance, honored donor Annie Stephenson Hostetler, honored caregiver Caroline Oliver and last year’s highlighted cancer patient Maddy Oliver. Ms. Oliver received a standing ovation for her victorious battle with cancer.

Gateway will use the money raised at Cures Gala to continue funding truly innovative phase I and phase II cancer clinical trials for all types of cancers affecting both adults and children. To make the greatest impact, Gateway commits 99 cents of every dollar received directly to cancer clinical trials, made possible by the underwriting of its administrative expenses by Cancer Treatment Centers of America.

“At Gateway we believe cures for cancer are within reach, and with the achievements of the Cures Gala fundraiser, we are significantly closer to realizing that vision,” said Teresa Bartels, President of Gateway for Cancer Research. “We are in an auspicious position to invigorate hope and new possibilities for cancer patients around the world.”

Cures Gala major sponsors include the Templer Family Foundation; Cancer Treatment Centers of America; Rising Tide Foundation; AmerisourceBergen; International Capital & Management Company; Katten Muchin Rosenman, LLP; Integrated Media Solutions; Bank of America Merrill Lynch; CliftonLarsonAllen; Bryan and Christina Cressey, Cressey & Company; Insight; Keystone Capital, LLC; Litchfield Advisors; N-Jet; OneNeck IT Solutions; The PrivateBank; Stellar Insurance Company, Ltd.; and T. Danis Charitable Trust.

For more information on Gateway for Cancer Research, visit GatewayCR.org.

About Gateway for Cancer Research
Gateway for Cancer ResearchSM is a nonprofit 501 (c)(3) organization committed to funding innovative cancer research and bold new ideas for lifesaving treatments that can make a difference today. Thanks to generous underwriting, 99 cents of every dollar received funds phase I and phase II cancer clinical trials around the world to help patients living with cancer to feel better, live longer and conquer cancer TODAY! Since its founding in 1991, Gateway has supported more than 120 clinical trials and funded millions in leading-edge research, including blending the best of conventional and complementary/alternative therapies. Get involved today by visiting GatewayCR.org, like us on Facebook at facebook.com/demandcures and join the conversation on Twitter @DemandCures.

Karen Kay, Gateway for Cancer Research, http://www.gatewaycr.org, +1 847.342.6477, [email protected]

Modal title

View PDF

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.